background antibiotics alter the microbial balance within the gastrointestinal tractprobiotics may prevent antibioticassociated diarrhea aad via restoration of the gut microfloraantibiotics are prescribed frequently in children and aad is common in this populationobjectives to assess the efficacy and adverse effects of probiotics any specified strain or dose for the prevention of antibioticassociated diarrhea in childrento assess adverse events associated with the use of probiotics when coadministered with antibiotics in childrensearch strategy medline embase central cinahl  amed and the web of science inception to august 2006 were searched along with specialized registers including the cochrane ibdfbd review group ciscom chalmers pedcam research register and trial registries from inception to 2005 letters were sent to authors of included trials nutrapharmaceutical companies and experts in the field requesting additional information on ongoing or unpublished trialsconference proceedings dissertation abstracts and reference lists from included and relevant articles were hand searchedselection criteria randomized parallel controlled placebo active or no treatment trials comparing coadministered probiotics with antibiotics for the prevention of diarrhea secondary to antibiotic use in children 0 to 18 yearsdata collection and analysis methodological quality assessment and data extraction were conducted independently by two authors bcj asdichotomous data incidence of diarrhea adverse events were combined using pooled relative risks and continuous data mean duration of diarrhea mean daily stool frequency as weighted mean differences along with their corresponding 95 confidence intervalsadverse events were summarized using risk differencefor overall pooled results on the incidence of diarrhea a priori sensitivity analyses included per protocol versus intention to treat random versus fixed effects and methodological quality criterionsubgroup analysis were conducted on probiotic strain dose definition of antibioticassociated diarrhea and antibiotic agentmain results ten studies met the inclusion criteriatrials included treatment with either lactobacilli spp bifidobacterium spp streptococcus spp or saccharomyces boulardii alone or in combinationsix studies used a single strain probiotic agent and four combined two probiotic strainsthe per protocol analysis for 910 trials reporting on the incidence of diarrhea show statistically significant results favouring probiotics over activenon active controls rr 049 95 ci 032 to 074however intention to treat analysis showed nonsignificant results overall rr 090 95 ci 050 to 163five of ten trials monitored for adverse events n  647 none reported a serious adverse eventauthors conclusions probiotics show promise for the prevention of pediatric aadwhile per protocol analysis yields treatment effect estimates that are both statistically and clinically significant as does analysis of high quality studies the estimate from the intention to treat analysis was not statistically significantfuture studies should involve probiotic strains and doses with the most promising evidence eg lactobacillus gg lactobacillus sporogenes saccharomyces boulardii at 5 to 40 billion colony forming unitsdayresearch done to date does not permit determination of the effect of age eg infant versus older children or antibiotic duration eg 5 days versus 10 daysfuture trials would benefit from a validated primary outcome measure for antibioticassociated diarrhea that is sensitive to change and reflects what treatment effect clinicians parents and children consider importantthe current data are promising but it is premature to routinely recommend probiotics for the prevention of pediatric aad